Overview
A Pharma Bulk Drugs Company located in Bidar, Karnataka, is seeking funding to enhance its operational production capacity. The company currently manufactures a range of 7-8 products, including sodium, tri-methyl chloride, acetylcysteine, and acetylglucosamine. Operating at only 20-25% of its potential, the manufacturing unit has a maximum production capacity of 50 tons per month. The facility is spread over 2.25 acres, with a built-up area of 75,000 square feet, including covered and shed spaces. The funding is required to boost production efficiency and scale operations to meet increasing market demands. With the proposed investment, the company aims to fully utilize its production capabilities and achieve a turnover of ₹80-100 crores annually. This opportunity represents a significant growth potential for investors or partners looking to enter or expand in the pharmaceutical bulk drugs industry. The established infrastructure and product portfolio provide a strong foundation for scaling up operations and capturing a larger market share.
Owned Pharmaceutical Industry API Bulk Drugs
Business Details
2018
Year of Establishment
300
No. of Employees
Running
Current Status of Business
NoBusiness Relocatable
Financial
Purpose of Joint Venture
Active
Role of New Partner
OwnedProperty Type
N.A Property Value
Industrial
Property Classification
Describe Property
2.25 acres land with 60 percent covered area
Proposed Deal Structure
N.A
Competition / Market
Yes, but very few
Products & Services
Pharaceutical Bulk drugs
Growth Potential
Very High
Financial Details
EBITDA :-
N.A
PAT :-
N.A
Debt :-
N.A
How the Acquisition Process Works
- 01Contact SellerContact Seller
- 02Teaser/Information MemorandumTeaser/Information Memorandum
- 03Valuation ReportValuation Report
- 04FinancialsFinancials
- 05Schedule an Advisory MeetingBook Your Consultation